Tower Research Capital (TRC)’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-353
Closed -$10.1K 6072
2024
Q1
$10.1K Sell
353
-1,256
-78% -$35.9K ﹤0.01% 3747
2023
Q4
$48.8K Buy
1,609
+1,239
+335% +$33.2K ﹤0.01% 3149
2023
Q3
$10.2K Buy
370
+282
+320% +$9.03K ﹤0.01% 4139
2023
Q2
$3.07K Sell
88
-563
-86% -$19.6K ﹤0.01% 5118
2023
Q1
$23K Sell
651
-173
-21% -$6.21K ﹤0.01% 3306
2022
Q4
$29K Buy
824
+213
+35% +$7.49K ﹤0.01% 2792
2022
Q3
$21K Buy
611
+592
+3,116% +$22K ﹤0.01% 3914
2022
Q2
$1K Buy
+19
New +$706 ﹤0.01% 5882
2021
Q4
Sell
-700
Closed -$37K 6659
2021
Q3
$37K Buy
+700
New +$38.7K ﹤0.01% 3208

Other funds holding HEAL

Tower Research Capital (TRC)'s HEAL Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q2 2024, closing a stake of 353 shares — an estimated $10.1K sold.

Tower Research Capital (TRC) first reported a position in HEAL in Q3 2021 and held it in 9 quarters. The position peaked at $48.8K in Q4 2023. 31 funds tracked by Wall St. Rank hold HEAL as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining Global X Funds Global X HealthTech ETF position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 353 Global X Funds Global X HealthTech ETF shares in Q2 2024, an estimated $10.1K.
  • Tower Research Capital (TRC) first reported a position in Global X Funds Global X HealthTech ETF in Q3 2021 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s Global X Funds Global X HealthTech ETF position peaked at $48.8K in Q4 2023.
  • 31 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.